Disorders of hemostasis in acute leukemia. I

H. Al Mondhiry

Research output: Contribution to journalArticle

Abstract

Bleeding is a major and at times catastrophic complication of acute leukemia (AL). In the untreated disease, hemorrhage occurs in approximately 75% of the patients at some time during the course of their short survival. Is is slightly more common in patients with acute lymphoblastic than in patients with acute myelogenous leukemia. Bleeding as a cause of death in AL has been significantly reduced since the introduction of platelet transfusion in the management of such patients. There are many underlying causes of hemorrhage in AL. The most frequent and the most important single factor is thrombocytopenia. Other defects in hemostasis such as clotting factor deficiencies, the occurrence of disseminated intravascular coagulation (DIC), abnormal fibrinolysis and impaired vascular integrity may also play a significant role. In this paper, the occurrence and pathogenesis of various defects in hemostasis and their contribution to bleeding in patients with AL are reviewed and possible methods of management discussed. (32 references)

Original languageEnglish (US)
Pages (from-to)3-10
Number of pages8
JournalClinical Bulletin
Volume5
Issue number1
StatePublished - 1975

Fingerprint

Hemostasis
Leukemia
Hemorrhage
Platelet Transfusion
Blood Coagulation Factors
Disseminated Intravascular Coagulation
Fibrinolysis
Acute Myeloid Leukemia
Thrombocytopenia
Blood Vessels
Cause of Death
Survival

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Al Mondhiry, H. / Disorders of hemostasis in acute leukemia. I. In: Clinical Bulletin. 1975 ; Vol. 5, No. 1. pp. 3-10.
@article{196ba4115c2c467c827802022506c766,
title = "Disorders of hemostasis in acute leukemia. I",
abstract = "Bleeding is a major and at times catastrophic complication of acute leukemia (AL). In the untreated disease, hemorrhage occurs in approximately 75{\%} of the patients at some time during the course of their short survival. Is is slightly more common in patients with acute lymphoblastic than in patients with acute myelogenous leukemia. Bleeding as a cause of death in AL has been significantly reduced since the introduction of platelet transfusion in the management of such patients. There are many underlying causes of hemorrhage in AL. The most frequent and the most important single factor is thrombocytopenia. Other defects in hemostasis such as clotting factor deficiencies, the occurrence of disseminated intravascular coagulation (DIC), abnormal fibrinolysis and impaired vascular integrity may also play a significant role. In this paper, the occurrence and pathogenesis of various defects in hemostasis and their contribution to bleeding in patients with AL are reviewed and possible methods of management discussed. (32 references)",
author = "{Al Mondhiry}, H.",
year = "1975",
language = "English (US)",
volume = "5",
pages = "3--10",
journal = "Clinical Bulletin",
number = "1",

}

Al Mondhiry, H 1975, 'Disorders of hemostasis in acute leukemia. I', Clinical Bulletin, vol. 5, no. 1, pp. 3-10.

Disorders of hemostasis in acute leukemia. I. / Al Mondhiry, H.

In: Clinical Bulletin, Vol. 5, No. 1, 1975, p. 3-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Disorders of hemostasis in acute leukemia. I

AU - Al Mondhiry, H.

PY - 1975

Y1 - 1975

N2 - Bleeding is a major and at times catastrophic complication of acute leukemia (AL). In the untreated disease, hemorrhage occurs in approximately 75% of the patients at some time during the course of their short survival. Is is slightly more common in patients with acute lymphoblastic than in patients with acute myelogenous leukemia. Bleeding as a cause of death in AL has been significantly reduced since the introduction of platelet transfusion in the management of such patients. There are many underlying causes of hemorrhage in AL. The most frequent and the most important single factor is thrombocytopenia. Other defects in hemostasis such as clotting factor deficiencies, the occurrence of disseminated intravascular coagulation (DIC), abnormal fibrinolysis and impaired vascular integrity may also play a significant role. In this paper, the occurrence and pathogenesis of various defects in hemostasis and their contribution to bleeding in patients with AL are reviewed and possible methods of management discussed. (32 references)

AB - Bleeding is a major and at times catastrophic complication of acute leukemia (AL). In the untreated disease, hemorrhage occurs in approximately 75% of the patients at some time during the course of their short survival. Is is slightly more common in patients with acute lymphoblastic than in patients with acute myelogenous leukemia. Bleeding as a cause of death in AL has been significantly reduced since the introduction of platelet transfusion in the management of such patients. There are many underlying causes of hemorrhage in AL. The most frequent and the most important single factor is thrombocytopenia. Other defects in hemostasis such as clotting factor deficiencies, the occurrence of disseminated intravascular coagulation (DIC), abnormal fibrinolysis and impaired vascular integrity may also play a significant role. In this paper, the occurrence and pathogenesis of various defects in hemostasis and their contribution to bleeding in patients with AL are reviewed and possible methods of management discussed. (32 references)

UR - http://www.scopus.com/inward/record.url?scp=0016681554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016681554&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 3

EP - 10

JO - Clinical Bulletin

JF - Clinical Bulletin

IS - 1

ER -